Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells

Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells

US Patent 8530508 · Granted Sep 10, 2013

Estimated economic value: $66,217,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-c2014
Methods of administration of thrombopoietin agonist compounds2013
Method of treating thrombocytopenia2013
Sialoadhesin factor-2 antibodies2012
Methods of use of sialoadhesin factor-2 antibodies2012
Methods of use of sialoadhesin factor-2 antibodies2011
Methods of use of bcl-6-derived nucleotides to induce apoptosis2010
Thrombopoietin mimetics2010
Thrombopoietin mimetics2010
Sialoadhesin factor-2 antibodies2009
Thrombopoietin mimetics2009
Thrombopoietin mimetics2008